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During hypoxic insult, neuronal tissue undergoes an excitotoxic cascade of events leading to cell 
death. This response involves loss of membrane potential and uncontrolled release of primarily 
excitatory  neurotransmitters.  
I propose that this fatal cascade is significantly delayed or attenuated in diving species, which are 
adapted to repeated exposures to hypoxic conditions as a consequence of breath-hold diving. 
Here I have compared the in vitro overflow/efflux of neurotransmitters from cerebellar slices of a 
diving bird, the common eider duck (Somateria mollissima) and of the non-diving chicken (Gallus 
gallus domesticus), using a microperfusion technique as described by Kirschner et al. (2009).  
Slices were cut in ice cold oxygenated aCSF and stored at room temperature before transfer to 
custom-made microperfusion chambers. After 20 min equilibration at 37°C, the superfusate was 
collected while exposing the slices to 20 min hypoxic or normoxic (control) perfusions, before 
reoxygenation. I used Waters UPLC AAA application solution for physiological amino acids to 
detect changes in the concentration of the excitatory neurotransmitters Glutamate and Serine and 
the inhibitory Glycine, in the superfusate. I found that neurotransmitter release, for both eider 
duck and chicken, tended to increase in hypoxia. In addition, higher levels of neurotrasmitter 












































Marine mammals and seabirds live in a challenging environment. They spend most of their life in 
the sea and under water. The diving feats of pinnipeds and cetaceans are well known. Research 
over decades has revealed a good picture about the diving physiology of marine mammals 
(Snyder, 1983b, Kooyman and Ponganis, 1998, Ramirez et al., 2007, Goldbogen et al., 2013). 
Recent studies confirm also that many species of seabirds are able to handle protracted and deep 
dives (Johansson and Aldrin, 2002, Wright et al., 2014). Thanks to physiological adaptations that 
have evolved over time, marine mammals like the hooded seal (Cystophora cristata) (fig.1.1) and 
seabirds like the emperor penguin (Aptenodytes forsteri), can hold their breath respectively for 
more than 50 and 10 minutes and dive respectively to more than 1000 and 400 m depth (Folkow 
and Blix, 1999, Wright et al., 2014). 
  
 
Figure 1.1 – Blueback, hooded seal (Cystophora cristata) when it is up to about 14 months of age. In the West Ice.  
Photo: Lorenzo Ragazzi 
 
 
1.1 Diving physiology  
Oxygen storage 
When diving, animals break contact with the atmosphere, therefore they need to carry O2 with 
them to enable tissues to function aerobically.  
Marine vertebrate are able to store oxygen in higher concentrations than land vertebrates. The 




in seabirds like penguins and diving mammals like hooded seals, it may reach 33 ml O2/kg to 50 ml 
O2 / kg respectively, two to five times higher (Costa, 2001, Burns et al., 2007).   
Because of high myoglobin concentrations, the skeletal muscles of some diving mammals appear 
almost black. In humans, skeletal muscles contain about 4-5 mg of myoglobin per gram wet weight 
(Möller and Sylvén, 1981). Hooded seals have 70-90 mg of myoglobin per gram wet weight (Burns 
et al., 2000, Lestyk et al., 2009). Diving birds also, like penguins and ducks, showed high myoglobin 
concentration, 4-64 mg per gram wet weight depending of the species (Weber et al., 1974, 
Stephenson et al., 1989, Ponganis et al., 1999). 
In relation to the blood oxygen storage and the cardiovascular system, the spleen plays an 
important role releasing red blood cells in the circulatory system during diving. In Weddell seals 
(Leptonychotes weddellii) it was measured a difference of 14% red blood cells (by volume) when 
the animal is resting and when the animal is diving (Qvist et al., 1986). Cabanac (2000) estimated 
that in hooded seals the splenic blood oxygen store may contribute by about the 9% of the total 
body oxygen store (Cabanac, 2000). An elevated red blood cells concentration increases the 
viscosity of the blood, the spleen has the role to partly store the red blood cells when the animal is 
not diving.    
The lungs of many shallow-diving species, such as seabirds, sea otters and some otariids, is an 
important O2 store (Costa, 2001). By contrast, deep-diving species normally exhale before diving, 
and their lungs collapse (Costa, 2001). This reflects a lack of support on lung O2 stores but also the 
need to avoid decompression sickness and reduce buoyancy during diving (Ramirez et al., 2007).  
 
Cardiovascular responses  
During short voluntary dives, the circulatory system remains open to almost all body regions and 
the tissues receive, from the body’s blood O2 storages, enough O2 to metabolize aerobically (Hill et 
al., 1989). Contrary, the O2 store is inadequate to sustain a constant supply of O2 during prolonged 
dives and such demand is difficult to satisfy. 
Throughout long-duration diving, in seals (Zapol et al., 1979) and ducks (Johansen, 1964), blood 
flow to most tissues is mostly reduced by vasoconstriction. The main portion of the stored O2 is 
reserved for the central nervous system (CNS hereafter) and heart, which in part dependent on 
aerobic catabolism for synthesis of ATP. The other tissues can turn to anaerobic metabolism, 




capacities, in marine mammals, avoid pH falling in tissue and blood due to the increase of CO2 and 
lactic acid (Snyder, 1983a). 
Because of the widespread vasoconstriction, the heart rate decreases, sometimes dramatically. 
Substantial diving bradycardia was first demonstrated during simulated diving in seals, by 
Scholander (1940), and has later been observed also during voluntary diving in a range of species, 
including gray seals (Halichoerus grypus) (Thompson and Fedak, 1993), harbor seals (Phoca 
vitulina) (Jobsis et al., 2001), emperor penguins (Aptenodytes forsteri) (Wright et al., 2014) and 
common eider duck (Somateria mollissima) (Hawkins et al., 2000).  
The massive peripheral vasoconstriction shuts down blood supply to most tissues. The blood PO2  
drops and in the brain, the blood supplied has a very low oxygen content, eventually, resulting in a 
severe hypoxemia (low blood oxygen content insufficient to sustain metabolic processes) (Meir et 
al., 2009). The critical arterial oxygen tension (the minimum amount of dissolved oxygen necessary 
to sustain aerobic metabolic processes) for (non-diving) mammals is 35-40 mmHg (Erecinska and 
Silver, 2001). Northern elephant seal (Mirounga angustirostris) have shown that cerebral integrity 
is maintained down to 23 mmHg (Meir et al., 2009) and in emperor penguins as low as 22 mmHg 
during dives (Ponganis et al., 2007). 
In diving animals, neither heart nor brain are entirely dependent on aerobic metabolism. Studies 
revealed that myocardial glycogen content, in isolated harp seal cardiomyocyte, is approximately 
10 times more than that of rats (Henden et al., 2004). In addition, during ischemia lactate 
production is significantly greater in seal compared to rat cardiomyocyte. Cellular ATP is well 
maintained and Ca2+  is not affected in ischemic seal cardiomyocyte, while in rat  ATP 65% decline 
and Ca2+ increase (Henden et al., 2004). In harbour seals (Phoca vitulina), during simulated diving, 
the lactate levels rise in the venous effluent from their head towards the end of the protracted 
dive, when the arterial blood O2 tension drops below 25 mmHg (Kerem and Elsner, 1973). 
Recordings from neocortical slices have also shown that these may maintain activity for up to 60 
min in hypoxia (Ramirez et al., 2011). Likewise, was recorded spontaneous activity for extended 
durations in cerebellar slices of eider ducks during induced anoxia (Ludvigsen and Folkow, 2009). 
The brain’s dependence on anaerobic metabolism increases as the animal becomes hypoxemic.  
The cardiac output in spotted seals (Phoca largha) and grey seals (Halichoerus grypus) during 
experimental diving decline 90% in the first 2-5 min of dive (Blix et al., 1983). Cerebral cortical and 
adrenal flow decrease and liver, kidney, fat, skin, and stomach became ischemic throughout the 





Hypometabolism, first conceptualized by Scholander (1940), is an important  strategy to cope with 
hypoxia. When a diving mammal or bird dive, there is an overall reduction in metabolism. This 
hypometabolic state, reduce the O2 requirements and consequently avoid the effects of hypoxia 
(Costa, 2001, Larson et al., 2014).  
 
1.2 Physiology of the diving brain 
Although many physiological adaptations of marine mammals and seabirds have been reported, 
little is known about the mechanisms that sustain the neuronal activity in the brain and how it can 
sustain the high demands for metabolic energy (O2 supply) during long hypoxic periods.   
Electrophysiological studies have shown that isolated cerebral neurons of adult hooded seal 
(Cystophora cristata) appear to exhibit an intrinsic hypoxia tolerance and that they can survive 
much longer at low oxygen levels than those of mice (Folkow et al., 2008). Similar studies using 
extracellular recordings of spontaneous activity in cerebellar slices from eider duck (fig. 1.2), 
chicken and rat, showed that avian neurons are more tolerant to hypoxia exposure than rat 
neurons and that eider duck neurons are even more hypoxia-tolerant than chicken neurons 
(Ludvigsen and Folkow, 2009), but the underlying mechanisms remain to be elucidated.  
Brain temperature measurements have shown that seals respond to experimental short dives with 
a controlled cooling of their brain, with a significantly decrease of 2°C in harp seals and 3°C degree 
in hooded seals (Odden et al., 1999, Blix et al., 2010). This observation suggested that these 
animals, may reduce their cerebral oxygen requirements by 25%, to extend their diving capacity 
(Blix et al., 2010). Which is one of the mechanisms by which hypometabolism can be achieved. A 
similar adaptation was recorded also in Pekin ducks (Anas platyrhynchos domestica), which during 





Figure 1.2 – Females of  common eider duck (Somateria mollissima). Photo: Erling S. Nordøy 
 
According to Glezer et al. (1987) and Kerem & Elsner (1973) some cerebral protection to 
hypoxemic challenge, is maybe offered by the high brain capillary density found in whales and 
seals, which reduce the diffusion distance and improve the flow of O2 to neurons (Kerem et al., 
1973, Glezer et al., 1987).  
An analogous of the oxygen-binding proteins hemoglobin and myoglobin, namely neuroglobin, 
which is predominantly expressed in the brain, was discovered by (Burmester et al., 2000). Today 
it is thought that the neuroglobin may play a key role for maintenance of aerobic metabolism in 
neural tissue by facilitating O2 diffusion. Furthermore this protein also has a detoxifying action of 
reactive oxygen species (ROS) (Burmester and Hankeln, 2009), which are generated during and 
after diving (Zenteno-Savin et al., 2002). Whales, have been shown to have neuroglobin mRNA 
expression levels that are 4 to 15 times higher than in seal, cow (Bos taurus) and ferret (Mustela 
putorius furo) brains (Schneuer et al., 2012). However, somewhat surprisingly, in seals cerebral 
neuroglobin levels are not higher than those of terrestrial mammals (Mitz et al., 2009). 
Nevertheless, a different distribution with higher levels in glial cells (astrocytes) than in neurons 
has been demonstrated, based on which it has been postulated that in seals, glial cells are 
probably more involved in aerobic metabolism than are neurons, which instead are assumed to 
have a high anaerobic capacity (Mitz et al., 2009, Schneuer et al., 2012). This neural based 
respiratory protein was also identified in chicken (Kugelstadt et al., 2004), however its distribution 





1.3 The anoxic brain  
Approximately 20% of the oxygen consumed by the resting human body is used by the brain 
(Bélanger et al., 2011). The greater part of this oxygen is used to produce the ATP, from glucose 
oxidation in the mitochondria, required to maintain the membrane potentials essential for 
electrical signaling with synaptic and action potentials. A lengthy interruption of the oxygen supply 
to the brain leads to irreversible neurological damage and neuronal death. The hippocampus 
neurons, and the Purkinje cells of the cerebellum seem to be among the most vulnerable neurons 
in relation to ischemic damage (Lutz et al., 2003). 
Without sufficient ATP production, ATP-dependent neuronal processes including ion transport 
cease, leading to efflux of   ions and inflow of      and     (fig. 1.3). Neurons consequently 
depolarize, followed by an uncontrolled release of excitotoxic neurotransmitters (e.g. Glutamate, 
Serine) (Lutz et al., 2003). High extracellular levels of excitatory neurotransmitters are cause of 
ischemic neuronal damage (Lutz et al., 2003). In particular glutamate plays an important role as an 
agonist of both the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (also known 
as AMPA receptor) the N-methyl-D-aspartate receptor (also known as NMDA receptor) (Lutz et al., 
2003). The activation of both those receptors, allows an increase of intracellular      levels with 
devastating consequences. The rise of      levels, 
acts as a trigger for the activation of enzymes such as 
lipases, endonucleases and proteases (Lutz et al., 
2003). D-ser is a coagonist (Shleper et al., 2005), 
necessary to activate the NMDA receptor and 
contribute to this so-called excitotoxicity (Kirschner et 
al., 2009). 
 
Figure 1.3 – Changes in creatine phosphate (CrP), ATP and 
extracellular ions concentration during ischemia in the rat brain 
(Lutz et al., 2003).                                          
 
1.4 Introduction of the methodology used  
Previous studies, gave already some information about the dynamic efflux of excitatory  (e.g. Glu, 
Ser) and inhibitory (e.g. Gly) neurotransmitters during cerebral ischemia. According to Kirschner et 
al. (2009), Glu is released within a few minutes after the onset of hypoxia, an early event in the 




several brain regions as a coagonist of the NMDA receptor (Katsuki et al., 2004). Gly, is well 
established as an inhibitory neurotransmitter in lower brain areas (Lutz et al., 2003). It is an 
antagonists of the D-ser (‘‘Gly’’) binding site, neuroprotective in animal models of stroke 
(Wasterlain et al., 1996, Ohtani et al., 2000, Ohtani et al., 2003). When inhibitory transmitters are 
released in large amounts (in hypoxia tolerant species), they act by depressing neural activity and 
hence ATP use and thereby protect (Nilsson, 1990, Nilsson et al., 1990).  
In hippocampus slice of rat, Thr levels increase during oxygen deprivation (OD) (Kirschner et al., 
2009). According to Kirschner (2009), the chemical similarity between Thr and Ser suggests that 
these two amino acids use similar transport mechanisms.  
Hypoxia-tolerant species as the turtle (Pseudemys scripta elegans) (Nilsson et al., 1990), the 
crucian carp (Carassius carassius) (Nilsson, 1990) and the arctic ground squirrels (Urocitellus 
parryii) (Ross et al., 2006, Drew et al., 2013), have shown a blunted excitotoxic response to 
hypoxia. However, no study has been conducted on diving birds and mammals. 
In the present study, single cerebellum slices have been used to monitor temporal efflux of Glu, 
Ser, Gly and Thr in response to oxygen deprivation in a diving and in a non-diving bird, the eider 
duck and the chicken.  
 
1.5 Objectives and hypothesis 
With this study I would like to test the hypothesis that the fatal hypoxia-induced excitotoxic 
cascade is significantly blunted also in diving species, which are adapted to repeated exposures to 
hypoxic conditions as a consequence of their breath-hold diving during feeding. In order to test 
this hypothesis I used a modified version of the approach used by Kirschner et al. (2009), to 
compare the in vitro temporal profile of efflux of neurotransmitters that play a crucial roles in the 
excitotoxicity cascade, from isolated brain slices during normoxic and simulated hypoxia 
conditions, in both a diving and a non-diving species. As a model organism I used the common 
eider duck (Somateria mollissima) and the chicken (Gallus gallus domesticus). The same 
experiment was also performed on hooded seals, however no results are available yet for this 
species or from a control (non-diving) mammalian species, due to time and analyzing capacity 
limitations.  
Research on neuronal adaptation to hypoxia of diving species might increase our knowledge of 
how the nervous system is adapted for life in specific ecological niches. Also this information could 








2. Materials and methods 
2.1 Animal handling 
All animal handling was conducted in the research animal facilities at the Arctic Biology building 
(ABB hereafter) of UiT The Arctic University of Norway. Samples have been collected from six eider 
ducks (Somateria mollissima) (tab. 2.1), which originated from birds collected as eggs on Grindøya 
outside Tromsø and reared in the research animal facilities at the ABB, and four chickens (Gallus 
gallus domesticus) (tab. 2.2), hatched and reared in similar conditions by a private owner 
(Professor Erling S. Nordøy). A suitable fenced outdoor area with a small pool, during the summer 
and an indoor facility, also with a pool in the winter season, ensured the well-being of the eider 
ducks. Samples have been collected also from eight hooded seals (Cystophora cristata). However, 
because of time limitations, the results from studies of the latter have not been completed and 
will therefore not be shown in this thesis. All experiments were conducted in accordance with 
current Norwegian legislation (The Animal Welfare Act and Regulations for use of animals in 
research (Forskrift for forsøk med dyr; FOR-1996-01-15-23)). 
 
 
2.2 Anesthesia & euthanasia  
The chickens and the eider ducks were anaesthetized with an intramuscular injection of Ketalar 
(ketamine hydrochloride 50 mg/ml, Pfizer Inc., New York, USA) and Xylazin (Rompun vet. xylazin 
chloride 20 mg/ml, Bayer AG, Leverkusen, Germany) (Green et al., 1981, Gales, 1989) before being 
euthanized by decapitation (tab 2.1.1 and tab 2.1.2). 
 






50 mg/ml Ketalar  
+ 
20 mg/ml Xylazin 
      
160913 16.09.2013 6 ♂ 1,84 0,5 ml Ketalar + 0,3 ml Xylazin 
180913 18.09.2013 6 ♂ 2,03 0,6 ml Ketalar + 0,3 ml Xylazin 
200913 20.09.2013 6 ♂ 1,95 0,7 ml Ketalar + 0,4 ml Xylazin 
230913 23.09.2013 6 ♀ 1,67 0,6 ml Ketalar + 0,3 ml Xylazin 
  
      












50 mg/ml Ketalar 
+ 
20 mg/ml Xylazin 
      
230813 23.08.2013 12 ♀ 1,83 0,8 ml Ketalar + 0,4 ml Xylazin 
270813 27.08.2013 12 ♀ 1,89 1,2 ml Ketalar + 0,6 ml  Xylazin 
290813 29.08.2013 12 ♀ 2,15 0,9 ml Ketalar + 0,5 ml  Xylazin 
020913 02.09.2013 12 ♂ 2,06 1,2 ml Ketalar + 0,6 ml  Xylazin 
040913 04.09.2013 12 ♂ 2,20 1,0 ml Ketalar + 0,5 ml  Xylazin 
060913 06.09.2013    12    ♀      2,00  1,2 ml Ketalar + 0,6 ml  Xylazin 
  
      
Table 2.1.2  Data for the eider ducks at the time of the experiment.  
 
2.3 Preparation of Artificial Cerebrospinal Fluid (aCSF) 
Neuron cells produce ATP with glucose and oxygen to maintain their metabolic processes and to 
keep their ionic gradient across the cell membrane. The aCSF mimics the extracellular 
environment and allows neurons to survive in vitro for at least 12 hours (Wang and Kass, 1997, 
Sveistrup, 2005).  
 
Compound mM g / 10 l 
NaCl 128 74.8 
KCl 3 2.2 
NaH2PO4 X H2O 0.5 0.6 
NaHCO3 24 20.15 
CaCl2 X 2H2O 1.5 2.2 
MgCl2 1.0 0.95 
D(+) Glucose 10 18.03 
Table 2.3.1 - Artificial cerebrospinal fluid recipe according to (Ludvigsen and Folkow, 2009). 
 
The final pH of the aCSF was adjusted to 7.4 ± 1 after 20 min saturation with a 5% CO2 and 95% O2 
gas mixture. The aCSF was kept at 5°C for not more than one week. Although the fluid should be  
stable for 3–4 weeks according to (Anonymous, 2011).   
 
2.4 Preparation of tissue blocks 
After the animal was decapitated the skull was handled inside a bucket filled with ice-cold aCSF. 
Low aCSF temperature slows down the metabolic rate and allows cells to survive the ischemic 




Within an average of 5 minutes after decapitation, the brain was removed from the skull and the 
dissection started. Using a sharp blade, cubes of 1 cm3 tissue were cut out of the cerebellum of 
the chickens and eider ducks.  
 
2.5 Vibratome method 
After dissecting, the tissue cube was fixed onto a stage for slicing (fig. 2.5.1) using cyanoacrylate 
glue (Loctite® Super Glue, Henkel Corporation, Westlake Ohio) to attach it to the stage. Two 
different vibratomes (Leica VT1000S, Leica Biosystems, Heidelberger, DE; OTS-3000, FHC 
Brunswick, ME) were used to prepare brain slices. A solid agar (agumedia, manufacturers, INC. 
Lansing, Michigan)  gel block (6 g in 100 ml of distilled water) was used to prevent the tissue from 
moving due to the vibratome blade (fig. 2.5.1). The speed was set in such a way that it did not 
twist the tissue while slicing. The vibratome was adjusted to cut slices 400 µm thick. According to 
(Wang and Kass, 1997) this thickness secures adequate diffusion of oxygen into the core of the 
slice. Slicing was performed at a cold temperature of 4°C, both tissue and blade were submerged 
in ice-cold aCSF aerated with 95% O2 and 5% CO2, CO2 must be present to stabilize the pH to about 
7.4 (fig. 2.5.1).  
After slicing, each slice was incubated inside a glass chamber in aCSF and aerated with 95% O2 and 
5% CO2 at room temperature for at least 20 minutes of equilibration. A metal net prevents the 
slices from sticking to the plexiglass wall (fig. 2.5.2). Electrophysiology recordings (Ludvigsen and 
Folkow, 2009) suggest that the slices incubated in such an incubation-chamber were able to 










Figure 2.5.2 - The slices were incubated in aCSF at room temperature and aerated with 95% O2 and 5% CO2. 
 
2.6 Microperfusion  
From the glass chamber, the slices have been transferred one by one, and placed, in a custom-
designed homemade brain slice microperfusion chamber, as described by (Kirschner et al., 2009). 
(The perfusion chamber dimensions are = 1,5 x 1,5 cm wide and 600 µm deep). Three scientific 
syringe drivers (Harvard apparatus, Millis, MA; Terumo STC-526, Somerset, NJ) (fig 2.6.2) were 




through an apparatus containing three parallel and completely water-tight microperfusion 
chambers, submerged in a thermostatically heated water bath at 37°C. Slices were perfused at a 
flow rate of ≈ 0,0234 ml/min (see Appendix I). The flow rate was dimensioned to the size of slices, 
based on the information given by Kirschner et al. (2009). 
The apparatus containing three parallel microperfusion chambers (two treatments plus one 
control) was submerged in a thermostatically controlled water bath set at 37°C (± 0,5°C), to secure 
stable temperature conditions. Sampling began after 20 min of slice equilibration to experimental 
conditions (temperature, perfusion environment) and for stabilization of the neurochemical efflux 
(Kirschner et al., 2009). Treatments consisted of a 24 min exposure to oxygen deprivation (a much 
longer period than the dive duration of a eider duck), by perfusing the chambers with aCSF 
equilibrated with 95% N2 / 5% CO2, or to control conditions (perfusion with aCSF equilibrated with 
95% O2 / 5% CO2). The microperfusion effluent was collected during intervals of 3 minutes to study 
neurotransmitters temporal response as an in vitro model for simulating diving (see sampling 
scheme fig. 2.6.1). The 3 min sampling interval was chosen in relation to the perfusion rate and 
the need for minimum sample size to run UPLC analyses of the constituents of the effluent, in 
triplicates. The effluent was collected in PCR vials (fig. 2.6.2) and stored at -20°C, until analysis. 
 
            
      Equilibration        Normoxia                      Treatment                                            Recovery 
 
Figure 2.6.1 – Perfusion experiment scheme: Equilibration, normoxia and recovery (aCSF equilibrated with 95% O2 / 
5% CO2), Treatment (aCSF equilibrated with 95% N2 / 5% CO2) ; H: Hypoxia; N: Normoxia; Black arrows: Analyzed 
samples.  
 
One should consider that the perfusion experiment might be influenced by factors like  flow rate, 
chamber dimension, lag time between pump and chamber and lag time between chamber and 
sample vial collector (see perfusion experiment scheme fig 2.6.1). To quantify the lag time factor, 
the flow profile was monitored using blue methylene in a separated experiment (without a slice). 




to the microperfusion chamber (fig. 2.6.2). This was taken into account in timing the sampling 
during the various treatments of the slices, and is referred to as the “transition” in fig.2.6.1.  
Due to the employing of syringe pumps (for control, treatment and second treatment as a 
backup), all of them were adjusted to have the same flow rate (see Appendix I). In order to 
improve the aCSF flow around the slice within the micro chambers, a titanium net was placed 
between the bottom and the tissue slice, also small cuts (0.5 mm width) were made on the inner 
lid of the micro chamber.  
At the end of the microperfusion experiments, each cerebellum slice was removed from the 






Figure 2.6.2 – On left side four syringe drivers used for perfusion. On right side the perfusion experiment scheme: 
Treatment (aCSF equilibrated with 95% N2 / 5% CO2), adaptation and recovery (aCSF equilibrated with 95% O2 / 5% 
CO2), valve, acute slice inside the micro chamber, collector of the efflux.   
 
 
2.7 Analysis   
2.7.1 General principles for Ultra-Performance Liquid Chromatograph analysis. 
All analyses of effluent composition were performed in the Barents Biocentre Lab (Tromsø, 
Norway), using a Ultra-Performance Liquid Chromatography (UPLC), Waters ACQUITY UPLC H-
Class, Waters Corporation, Milford, MA USA. 
The Ultra-Performance Liquid Chromatography (UPLC) has the ability to separate, identify, and 
quantify the compounds that are present in any sample that can be dissolved in a liquid. The 




1 µl of the sample (3) is transferred from the sample vial into a moving fluidic stream, the mobile 
phase (1). The injected sample is then carried by the mobile phase to the head of a 
chromatographic column (hydrophobic stationary phase) (4) by a high pressure pump (2) (fig. 
2.7.1). The reversed-phase chromatography is based on the principle that hydrophobic molecules 
in the mobile phase tend to be adsorbed during the hydrophobic stationary phase, and hydrophilic 
molecules in the mobile phase will pass through the column and are eluted first.  
 
 
Figure 2.7.1 - Representation of an HPLC/UPLC system (www.waters.com) 
 
 
Through the column the sample is separated into individual analytes, called “bands”. Each of these 
bands moves through the column at different speeds, because of the competition between the 
mobile phase and the stationary phase for attracting each one of the analytes.  
As the separated bands leave the column, they pass immediately into a detector (5) (UV detector, 
Waters ACQUITY UPLC® Photodiode Array (PDA) eλ Detector). Peaks (visible in the chromatogram) 
are digitally created as an electronic response to the analyte band as it passes through the 
detector (6) (www.waters.com). A chromatogram is a representation of the separation (4) that has 
chemically (chromatographically) occurred in the UPLC system. The retention time is the amount 
of time elapsed from the injection (3) of a sample into the UPLC system to the recording (6) of the 
peak (band) maximum of the component in the chromatogram (www.waters.com). 
Some analytes require derivatization prior to UPLC analysis. The derivatization process makes an 
analyte more volatile, less reactive, and thus improve its chromatographic performance. Amino 




and SH polar functional groups) with a nonpolar moiety. The derivatization process is described in 
paragraph 2.7.2 and 2.7.3.  
All analyses were performed, using Waters ACQUITY UPLC® Photodiode Array (PDA) eλ Detector, 
connected with MassLynxTM Software (Waters Corporation, Milford, MA USA). Furthermore, an 
Acquity UPLC BEH (bridged ethylsilaxane/silica hybrid structure) C18 column (2.1 mm × 150 mm, 
1.7 μm) as stationary phase, also from Waters, was used. The column temperature was 
maintained at 43 °C. The system was checked by use of standard solutions with known amounts of 
the analytes. The standards and samples were separated using a mobile phase consisting of AccQ-
Tag Ultra Eluent A - 1:10 dilution and AccQ-Tag Ultra Eluent B. The flow rate was set at 400 µL/min 
and the injection volume at 1 μL. The detection wavelength was set at 260 nm (see Appendix II). 
The Waters AccQ-Tag Ultra Derivatization Kit was used for the UPLC amminoacid analysis. Each kit 
of reagents consist of one vial each of:  
- Ultra Borate Buffer – The buffer is added to the samples to ensure the optimum pH for 
derivatization.  
- Ultra Reagent Powder – 6-aminoquinolyl-N-hydroxysuccinimidyl carbonate (AQC) 
derivatizing reagent.  
- Ultra Reagent Diluent – This diluent, acetonitrile, is used to reconstitute the reagent for 
derivatization.  
 
2.7.2 Sample preparation 
The amino acid derivatives were prepared by mixing an aliquot of a sample (or of the standard 
solution containing 16 standard amino acids, Amino Acid Hydrolysate Standard, 10 x 1 mL 
WAT088122, Waters Corporation, Milford, MA USA) with the borate buffer and the derivatizing 
solution. The derivatizing solution was prepared according to instructions (Instruction manual, 
Appendix III), by dissolving the Ultra Reagent Powder in 1 ml Ultra Reagent Diluent. Furthermore, 
the solution was mixed for 10 seconds and heated on top of a heating block at 55°C (Stuart 
SBH200D/3 Stone, UK) for 15 minutes. During these 15 minutes, every five minutes the solution 
was vortexed (Vortex MS 3 basic Staufen Germany). After the reagent was reconstituted (see 
instruction manual, Appendix III), 10 µl of the sample was added and mixed for 15 seconds with 70 
µl of Ultra Borate Buffer. Subsequently 20 µl of reconstituted AccQ•Tag™ Reagent was added to 
the vial and mixed for 10 seconds. After leaving it for one minute at room temperature the vial 




To avoid contamination of the sample, the preparation was performed inside a ventilated hood, 
wearing nitrile gloves.    
Micropipettes (Proline Plus Pipette 0.5-10 μl, 10-100 μl, 20-200 μl Sartorius Corporate 
Administration Gmb Weender Landstr., Goettingen) and Pipette tips (5-200 μl Thermo Fisher 
Scientific Oy Vantaa, Finland) were used during the sample preparation.   
 
2.7.3 Reaction scheme 
The AccQ•Tag™ derivatization reagent reacts rapidly with amines through nucleophilic attack. The 
result is the loss of N-hydroxysuccinimide (NHS) and CO2 (fig. 2.7.3). The resulting stable 
derivatives are now ready for analysis. Primary and secondary amino acids are derivatized quickly, 
on a milliseconds time scale, and they are stable for more than one week at room temperature 
(Instruction manual, Appendix III). The excess reagent reacts more slowly with water, hydrolyzing 
in a few tens of seconds  (http://www.knauer.net/.).  
Problems were identified initially due to the use of Ortho-phthalaldehyde (OPA) (a different 
derivatization reagent for amino acids). OPA derivatization was excluded, as some amino acid 
derivatives were stable only for a few minutes. 
 
 






2.7.4 Use of an internal standard  
Internal standards (IS hereafter) are commonly used in chromatography. The D-Norvaline (Sigma-
Aldrich Co. LLC  St. Louis, Missouri), a structural isomer of Valine, was chosen as IS. This amino acid 
has a similar retention time and similar derivatization reaction as our analytes. This standard is 
stable, does not interfere with the sample and is not present in normal biological samples. 
The correct concentration of each analyte was derived based on comparing their chromatogram 
peaks with those obtained by adding a known amount of Norvaline (to yield 100 pmol/µl), by 
integrating the area under the peaks formed for each analyte (including D-Norvaline). This was 
done also to correct the eventual slight variation of the instrument detector response.  
 
2.7.5 Cleaning system  
To ensure the quality of results the ACQUITY UPLC system was cleaned following the Waters 
MassTrak Amino Acid Analysis Solution System Guide, 2008 (see Appendix IV). Initially, failure to 
clean the system and to use solvents (e.g. acetonitrile and water) of HPLC grade, resulted in high 
background contamination, poor signal-to-noise ratio, and loss of sensitivity, with consequent 
difficulties in reading the chromatograms. This problem was corrected by using the correct type of 
cleaning procedure. 
 
2.7.6 Calibration curves 
A solution of mixed standards from Waters was prepared and diluted to the appropriate 
concentration for the establishment of calibration curves. Four concentration level standards (25, 
50, 100 and 200 Pmol/µl) were injected in triplicates. Then the calibration curves were 
constructed by plotting the peak area of the analyte (e.g. Glu) divided by the peak area of the IS, 
versus the concentration of the standard analyte (e.g. Glu) divided the concentration of the IS (see 
Appendix V). 
The IS was used in the formula below to correct the eventual slight variation of the instrument 
detector response and to extrapolate the real concentration of the analyte in the sample. 
 
         
    
  
         
    





The quotient Area Analyte/Area IS, is given by the peak area of the analyte (chromatogram peak) 
divided by the peak area of the IS. The quotient Concentration Analyte/Concentration IS, which 
take into account the final concentration in the solution, is given by the concentration of the 
analyte in sample (unknowns) divided by the concentration of the IS (100 pmol/µl, fixed 
concentration added to each sample). The slope m and y-intercept q are given by the calibration 
curves (obtained by use of the Waters standard) for each single analyte (Appendix V).    
 
2.8 Statistics 
The statistical analysis of data containing repeated measurement, allocated to different 
treatments over time, as in this case, may be challenging. Repeated measures data are often 
analyzed by repeated ANOVA. However, this model present limitations when there are missing 
measurements, or when some of the data are measured at different times. Such data are excluded 
resulting in insufficient information for a meaningful analysis. The presence of unequally 
(temporally) spaced and/or missing data does not pose a problem for the Mixed Model approach 
(Wang and L. A. Goonewardene, 2004). The Mixed Model uses the generalized least squares 
method, which is more powerful than the ordinary least squares used by a General Linear Model. 
Another key reason to use the Mixed Model was to analyse repeated measurement, something 
which is not possible with the General Linear Model.  
Results of analyses of individual samples were obtained as the means of three replicate analyses, 
both for the controls and the treatments. Linear Mixed Model with Bonferroni correction for 
multiple measurements was used to determine significant differences between treatment and 
control and for pairwise comparison. Temporal efflux of neurotrasmitter was also evaluated using 
the Mixed Model to identify the trend of the analyte over time.  
In the data analysis, only repeated measures (n=3) with a CV below 10% were taken into 
consideration. All statistical tests were evaluated at the 95% confidence level as the threshold for 
significance. All the statistics is showed in  Appendix VI. 
Statistical analyses were carried out with IBM SPSS Statistics for Windows, Version 22.0. Armonk, 











3.1 Chromatograms of Waters standard amino acids.  
The standard chromatogram (figure 3.1.1) shows the separation of 16 standard Waters amino 
acids and the added Norvaline.  
The reproducibility of the assay was shown by performing intra and inter-run precision tests. The 
intra-run precision test (n=3) was performed over a one day period (three vials with derivatized 
standard amino acids were analysed in triplicate at different time over a day)  (table 3.1.1) and the 
inter-run precision (n=3) over a three weeks period (three vials with derivatized standard amino 
acids were analysed in triplicate at different time over a three weeks) (table 3.1.2). The %CV 





Figure 3.1.1 – Typical chromatogram showing the separation of Waters standard amino acids (100 Pmol/μL) using the 
UPLC amino acid analysis. The standard contains 16 amino acids and the Norvaline (NVa) (added afterwards) as the 
internal standard. X-axis: retention time. Y-axis: absorbance (AU). Std Peak: Derivatization reagent peak. The first 
number above the peak indicate the exact retention time (X-axis). The second number above the peak indicate the 









Amino acid Peak area (100 
pmol/μL) 
SD (100 Pmol/μL) CV (%) 
Glu 1153 29.9 2.6 
Ser 1236 14.9 1.2 
Gly 1224 6.8 0.5 
Thr 1253 5.5 0.4 
Table 3.1.1 - Intra-run precision test performed over one day with the Waters standard amino acids of interest (100 
pmol/μL). Peak area: Mean peak area as derived from three intra-run tests, each with triplicate analyses, SD: standard 
deviation, CV: coefficient of variation. 
 
 
Amino acid Peak area (100 
Pmol/μL) 
SD (100 Pmol/μL) CV (%) 
Glu 1172 42.6 3.6 
Ser 1244 10.9 0.9 
Gly 1228 13.6 1.1 
Thr 1246 23.0 1.8 
Table 3.1.2 - Inter-run precision test performed over a three weeks period with the Waters standard amino acids of 
interest (100 pmol/μL). Peak area: Mean peak area as derived from three inter-run tests, each with triplicate analyses, 
SD: standard deviation, CV: coefficient of variation. 
 
 
Standard chromatograms comparison showed that there was no difference in the retention time 
between Waters standard amino acids diluted in water and in aCSF (figure 3.1.2 – 3.1.3). 
According to this, looking at the retention time, it was assumed that unknown peaks in aCSF 
samples were represented by the amino acid that had the same/similar retention time in the 
Waters standard.   
Blank samples containing only water and blank samples containing only the matrix (aCSF), were 
derivatized. The result was a single visible peak (the derivatization peak), without cross-reactions 
between the derivatization agent and components of the aCSF. Contaminants are not present 




Figure 3.1.2 – Chromatogram showing the separation of Waters standard amino acids diluted in water (100 Pmol/μL). 
X-axis: retention time. Y-axis: absorbance (AU). The first number above the peak indicates the exact retention time (X-







Figure 3.1.3 – Chromatogram showing the separation of Waters standard amino acids diluted in aCSF (100 Pmol/μL). 
X-axis: retention time. Y-axis: absorbance (AU). The first number above the peak indicates the exact retention time (X-




Figure 3.1.4 – Chromatogram showing the derivatized blank matrix (aCSF) sample. X-axis: retention time. Y-axis: 
absorbance (AU). The first number above the peak indicates the exact retention time (X-axis). The second number 




Figure 3.1.5 – Chromatogram showing the derivatized blank Millipore water sample. X-axis: retention time. Y-axis: 
absorbance (AU). The first number above the peak indicates the exact retention time (X-axis). The second number 






3.2 Chromatograms of duck and chicken samples 
Ultra Performance Liquid Chromatography (UPLC), on physiological samples of eider duck and 




Figure 3.2.1 – Typical example of chromatogram showing derivatized physiological sample of eider duck, during the 
first three minutes sampling in normoxia exposure. X-axis: retention time. Y-axis: absorbance (AU). The first number 





Figure 3.2.2 – Typical example of chromatogram showing derivatized physiological sample of eider duck, during 
hypoxia exposure (minute 39). X-axis: retention time. Y-axis: absorbance (AU). The first number above the peak 







Figure 3.2.3 – Typical example of chromatogram showing derivatized physiological sample of eider duck, during 
recovery in normoxia, after hypoxia exposure (minute 84). X-axis: retention time. Y-axis: absorbance (AU). The first 
number above the peak indicate the exact retention time (X-axis). The second number above the peak indicate the 
peak area.    
 
3.3 Efflux of neurotransmitter.   
Cerebellum slices were cut following the procedure explained in the paragraph 2.5. The success of 
the procedure was proven by electrophysiological population recordings, showing that slices were 
still viable after the treatment (Appendix VII).  
Analysis were performed to monitor the efflux of Glu, Ser, Thr and Gly in the perfusion 
experiments.  
The standard curve (see paragraph 2.7.5 and Appendix V) was used to calculate the actual 
concentration of each peak area given by the chromatogram. The regression lines for 
concentrations versus peak areas for Gly, Ser, Thr and Glu showed coefficients (R2) ranging from 
0.9994 - 1.00 (see Appendix V).  
 
Concentration calculations.  
Results are means of three replicates. The mean peak area was adjusted using the Internal 
Standard, Norvaline, according to the formula presented in paragraph 2.7.5.  
         
    
  
         
    
   
In order to adjust the amounts of released amino acids for differences in the size of slices used, 
the amino acid values were divided by the weight of each brain slice (wet weight). The final value 




Cerebellum slice weight 
At the end of the microperfusion experiments, each cerebellum slice was removed from the 








(g) wet weight  
Treatment 
Chicken 
(g) wet weight  
Control  
Chicken 
(g) wet weight  
160913   0.0643 0.0699 
180913   0.0537 0.0560 
200913   0.0458 0.0479 
230913   0.0861 0.0647 
270813 0.1055 0.1083   
290813 0.1048 0.0597   
020913 0.0726 0.0734   
060913 0.0752 0.0786   
Average  0.0895 0.0800 0.0625 0.0596 
Table 3.3 – Cerebellum slice weight for chickens and eider ducks. ID: The animal ID correspond to the date of the 




A Linear Mixed Model with Bonferroni correction for multiple measurements was used to 
determine significant differences between treatment and control and for pairwise comparison. 
The results were evaluated at the 95% confidence level as threshold for significance.   
Upon hypoxia exposure, Glu release from eider duck cerebellar slices (fig. 3.4.1) showed a rise 
(minute 27), followed by a slow decrease which continued into the reoxygenation phase. 
Normoxic control slices showed no increase, only a slow decrease throughout the perfusion 
experiment. Glu release from chicken cerebellar slices (fig. 3.4.2) showed a slightly increased, not 
confirmed by pairwise comparison, followed by a decrease into the reoxygenation phase. 
Normoxic control slices showed quite stable efflux of Glu throughout the perfusion experiment. 
Thr (fig. 3.4.3) and Ser (fig. 3.4.5) and Gly (fig. 3.4.7) release from eider duck cerebellar slices 
showed a rise, after minute 27, consistent throughout both the hypoxia and the reoxygenation 
phase. Normoxic control slices showed quite stable efflux throughout the perfusion experiment. 




and Gly but not confirmed by pairwise comparison. Normoxic control slices showed a slow 
decrease of Ser efflux throughout the perfusion experiment, also confirmed by pairwise 
comparison. 
There was a significant difference between the treatment (hypoxia) and the control (normoxia) for 
Glu, Thr, Ser and Gly in both eider ducks and chickens (p < 0,05), with a higher levels of 
neurotrasmitter efflux during the hypoxia exposure (tab. 3.4.1) (fig. 3.4.1 to fig. 3.4.8). Temporal 
variation was a significant factor only for the efflux of Glu in the eider ducks group (F: 3,3005,41 p = 
0,014) (tab. 3.4.2) and for the efflux of Ser in the chickens group (F: 2,6995,41 p = 0,034). There was 
no significant change with time in the efflux of the different amino acids, in different experiments 
(tab.3.4.3).  
Pairwise comparisons showed that the efflux of all amino acids (fig. 3.4.1, 3.4.3, 3.4.5, 3.4.7 and 
tab 3.4.4) was significantly higher for hypoxia-exposed eider duck slices than for controls. The 




Figure 3.4.1 – Efflux of Glutamate over time in four eider ducks. Blue: treatment (hypoxia followed by reoxygenation), 
red: control (normoxia throughout). Shaded (grey area) period of hypoxia exposure for treatment slices. Data are 
given as means ± standard deviation between individuals. Asterisk marks pair-wise significant difference (p < 0.05) 
between treatment and control (based on the linearly independent pairwise comparisons among the estimated 






Figure 3.4.2 – Efflux of Glutamate over time in four chickens. Black: treatment (hypoxia followed by reoxygenation), 
green: control (normoxia throughout). Shaded (grey area) period of hypoxia exposure for treatment slices. Data are 





Figure 3.4.3 – Efflux of Threonine over time in four eider ducks. Blue: treatment (hypoxia followed by reoxygenation), 
red: control (normoxia throughout). Shaded (grey area) period of hypoxia exposure for treatment slices. Data are 
given as means ± standard deviation between individuals. Asterisk marks pair-wise significant difference (p < 0.05) 







Figure 3.4.4 – Efflux of Threonine over time in four chickens. Black: treatment (hypoxia followed by reoxygenation), 
green: control (normoxia throughout). Shaded (grey area) period of hypoxia exposure for treatment slices. Data are 





Figure 3.4.5 – Efflux of Serine over time in four eider ducks. Blue: treatment (hypoxia followed by reoxygenation), Red: 
control (normoxia throughout). Shaded (grey area) period of hypoxia exposure for treatment slices. Data are given as 
means ± standard deviation between individuals. Asterisk marks pair-wise significant difference (p < 0.05) between 






Figure 3.4.6 – Efflux of Serine over time in four chickens. Black: treatment (hypoxia followed by reoxygenation), green: 
control (normoxia throughout). Shaded (grey area) period of hypoxia exposure for treatment slices. Data are given as 
means ± standard deviation between individuals. Asterisk marks pair-wise significant difference (p < 0.05) between 







Figure 3.4.7 – Efflux of Glycine over time in four eider duck. Blue: treatment (hypoxia followed by reoxygenation), 
Red: control (normoxia throughout). Shaded (grey area) period of hypoxia exposure for treatment slices. Data are 
given as means ± standard deviation between individuals. Asterisk marks pair-wise significant difference (p < 0.05) 






Figure 3.4.8 – Efflux of Glycine over time in four chickens. Black: treatment (hypoxia followed by reoxygenation), 
green: control (normoxia throughout). Shaded (grey area) period of hypoxia exposure for treatment slices. Data are 
given as means ± standard deviation between individuals. Asterisk marks pair-wise significant difference (p < 0.05) 












Glutamate Eider .000 



















Table 3.4.1 – Significant difference between the treatment (hypoxia) and the control (normoxia) for Glu, Thr, Ser and 
Gly in both eider ducks and chickens. 1: Looking at the effect of the experiment (treatment and control). Fixed factors: 
Experiment (treatment and control) a: Adjustment for multiple comparisons: Bonferroni. Data were split for chemical 









Effect of the temporal variation (time) on the experiment (treatment and control) - 





Glutamate Eider .014 



















Table 3.4.2 - Significant difference between the treatment (hypoxia) and the control (normoxia) for Glu, Thr, Ser and 
Gly in both eider ducks and chickens. 1: Looking at the effect of the temporal variation (time) on the experiment 
(treatment and control). Fixed factors: Experiment (treatment and control), time. a: Adjustment for multiple 










Glutamate Eider .791 



















Table 3.4.3 - Significant difference between the treatment (hypoxia) and the control (normoxia) for Glu, Thr, Ser and 
Gly in both eider ducks and chickens. 1: Assumption of different slopes. Fixed factors: Experiment (treatment and 
control), time, interaction time and experiment. a: Adjustment for multiple comparisons: Bonferroni. Data were split 











Pair-wise significant difference 
Chemicals 
 
Species Time (min) Sig. 
a 
Glutamate Eider 27 .047 





















































































Table 3.4.4 - Pair-wise significant difference (p < 0.05) between treatment (hypoxia) and control (normoxia) (based on 
the linearly independent pairwise comparisons among the estimated marginal means for Glu, Thr, Ser and Gly in both 
eider ducks and chickens. Fixed factors: Time. a: Adjustment for multiple comparisons: Bonferroni.  Data were split for 
chemical, time and species.  
 
 
There was a significant difference in the effect of treatment, between the eider duck and chicken 
group for Glu (F: 5,4391,41 p = 0,025), Thr (F: 24,1071,86 p < 0,001), Ser (F: 14,2461,86 p < 0,001), and 
Gly (F: 4,7701,85 p = 0,032) (tab. 3.4.5).  Higher levels of neurotransmitter efflux during the hypoxia, 
and normoxia exposure were present in the chicken group (fig. 3.4.9 to fig. 3.4.12). Temporal 





Figure 3.4.9 – Efflux of Glutamate over time in four eider duck and four chickens. Black: treatment (hypoxia followed 
by reoxygenation) in chickens, blue: treatment (hypoxia followed by reoxygenation) in eider duck. Red: control 
(normoxia throughout) in eider duck. Green: control (normoxia throughout) in chicken. Shaded (grey area) period of 




Figure 3.4.10 – Efflux of Threonine over time in four eider duck and four chickens. Black: treatment (hypoxia followed 
by reoxygenation) in chickens, blue: treatment (hypoxia followed by reoxygenation) in eider duck. Red: control 
(normoxia throughout) in eider duck. Green: control (normoxia throughout) in chicken. Shaded (grey area) period of 





Figure 3.4.11 – Efflux of Glycine over time in four eider duck and four chickens. Black: treatment (hypoxia followed by 
reoxygenation) in chickens, blue: treatment (hypoxia followed by reoxygenation) in eider duck. Red: control (normoxia 
throughout) in eider duck. Green: control (normoxia throughout) in chicken. Shaded (grey area) period of hypoxia 






Figure 3.4.12 – Efflux of Serine over time in four eider duck and four chickens. Black: treatment (hypoxia followed by 
reoxygenation) in chickens, blue: treatment (hypoxia followed by reoxygenation) in eider duck. Red: control (normoxia 
throughout) in eider duck. Green: control (normoxia throughout) in chicken. Shaded (grey area) period of hypoxia 







Significant difference in the effect of treatment and control, between the eider duck and chicken. 





Glutamate Control .000 



















Table 3.4.5 – Significant difference in the effect of treatment and control, between the eider duck and chicken for Glu, 
Thr, Ser and Gly. 1: Looking at the effect of the treatment and control. Fixed factor: Species. a: Adjustment for 






Effect of the temporal variation (time).  





Glutamate Control .175 



















Table 3.4.6 – Significant difference in the effect of treatment and control, between the eider duck and chicken for Glu, 
Thr, Ser and Gly. 1: Looking at the effect of the temporal variation (time). Fixed factors: Species and time. a: 









4. Discussion  
4.1 Potential sources of errors 
Use of Ultra Performance Liquid Chromatography (UPLC) to analyse the amino acid composition in 
physiological samples, showed good peak resolution and low chromatographic interferences (fig. 
3.2.1, 3.2.2, 3.2.3), which suggests that the Waters MassTrak Amino Acid Analysis (AAA) Solution 
(Anonymous, 2008) was a reliable method for these analyses.  
Electrophysiological population recordings (Appendix VII), showed clear slice vitality, with 
spontaneous discharge activity that is typical for the Purkinje layer of duck cerebellar slices (e.g., 
Ludvigsen and Folkow 2009). The same recording was performed on cerebellum slices after the 
microperfusion experiment. Vitality, even if weaker, showed that the slices survived after 84 
minutes of microperfusion for both treatment and control.   
The proven vitality of slices, indicates that the correct settings were chosen for perfused flow rate 
(0.0234 ± 0.0015 ml/min, see Appendix VII). The flow rate was adjusted by taking into 
consideration the average size of the slices in the study by Kirschner et al. (2009). Consequently, 
the perfusion flow rate for cerebellum slices was increased by three times compared to that used 
for hippocampus slice (7 µl/min) by Kirschner et al. (2009).   
The Waters MassTrak™ method, for use in the high throughput analysis of amino acids, was found 
robust, reliable, and reproducible (see discussions 4.2) 
 
4.2 Development of the method analysis  
Early advice on use of the Ultra-Performance Liquid Chromatographic (UPLC) analysis of amino 
acids that proved to be wrong, led to some initial mistakes and problems with proper reading and 
interpretation of the results. In the beginning, chromatograms showed interfering peaks and 
baseline disturbances. These methodological hitches had their roots in the wrong use of the 
mobile phase and the fact that the need for a routine cleaning process of the instrument (see 
Appendix IV) was not considered. These routines were changed after a conference with the 
Waters company. Initially, self-made eluents (water/acetonitrile and acetonitrile/formic acid, 
commonly used for amino acid analysis) were used, but, again after consultation with the Waters 
company, their advice of using the Waters MassTrak™AAA kit was followed. This proved to be a 
robust, reliable, and reproducible method (see paragraph 4.3), and inaccuracies were considerably 




(Anonymous, 2008). In order to reduce the analysing time and cost, the running time was reduced 
from 45 minutes (Anonymous, 2008) to 32 minutes. The results, after run time shortening, still 
showed no critical peak interference (Appendix II).  
 
4.3 Validation of the method  
Linearity  
The linearity of the method of the mathematical relationship between the different concentration 
of the analyte (pmol/µl) and the response peak area, graphically represented as a straight line, 
was calculated by analyzing standard amino acids from Water (fig. 3.1.1) at four different 
concentration levels (25, 50, 100 and 200 pmol/µl). The calibration curve was constructed by 
plotting the response area of the analyte divided by the response area of the Internal Standard 
(Norvaline), against the corresponding concentration injected of the analyte divided by the known 
concentration of injected Norvaline, using the least square method (Appendix V). The high value of 
the correlation coefficient (r2) 0.999 for Glu, Thr, Ser and Gly calibration curve, indicates good 
linearity (Kumar et al., 2011). 
 
Specificity  
The capability of this method to separate and accurately measure the peaks of interest (fig. 3.1.1) 
indicates the specificity of the method. The specificity of the method was checked by injecting 
standard amino acids from Waters, together with the aCSF sample from the microperfusion 
experiment (fig. 3.1.2). No interference of the matrix components was observed, with regard to 
the retention time of analyte peak (Kumar et al., 2011, Rane et al., 2012). 
 
Precision  
The precision of the chromatographic method, was estimated by measuring repeatability and 
time-dependent intermediate precision based on three replicated injections. The low CV values 
(%) presented in tab. 3.1.1 and 3.1.2 illustrate the good precision of the analytical method. In the 
data analysis, only repeated measures (n=3) with a CV below 10% were taken into consideration.  
 
Solution stability  
The stability of amino acid in the aCSF and standard solution was tested. The samples and 




injected into the UPLC system at different time, throughout 8 weeks. The chromatographs of the 
stored samples were reliable; standards showed high repeatability independent of age and no 
additional/anomalous peaks were registered.   
 
4.4 Brain slice vitality   
The brain-slice technique is utilized mainly in electrophysiology (Wang and Kass, 1997). In this 
study,  electrophysiological recordings of neuronal population activities were only used to monitor 
the vitality of slices before and after microperfusion in aCSF. Recorded activity was taken to 
indicate that slices were still alive after the experimental treatment (see Appendix VII).  
Obviously, the procedures described (paragraph 2.3-2.6) had the objective to keep the brain tissue 
alive. Some care must be taken in each step to avoid problems, which may be due to the following 
potential sources of errors:  
- The process of decapitation and extraction of the brain, before the slice is placed in the 
aCSF bath solution, may have effects on the brain tissue. Less than 5 minute were used to 
extract the brain after decapitation. Extraction and brain manipulation were conducted in a 
cold aCSF bath (< 5°). Low aCSF temperature slows down the metabolic rate and allows 
cells to survive the ischemic period during carrying and dissecting. 
- The slicing method may itself compromise the brain tissue. Slicing of the tissue block can 
damage the top and bottom of the section. During microperfusion, the tissue also "ages", 
degrading at a faster rate than in the intact animal brain. Last but not least, the aCSF 
composition requires the necessary compounds in the right concentration (Sveistrup, 2005, 
Anonymous, 2011). 
- The most delicate step is the transfer of the cerebellum slice into the microperfusion 
chamber. The brain tissue was handled delicately to reduce any physical damage. 
Microperfusion of  squeezed or twisted slices was not performed.  
- Microperfusion was performed with aCSF equilibrated with 5% CO2 and 95% O2 or with 
95% N2 and 5% CO2. However, a measurement of the actual oxygen tension inside the 
microchamber was not possible. An attempt was made to use an oxygen sensor (Unisense, 
DK-8200 Aarhus N, Denmark) for this purpose, but without success, for the fine tip of the 




- The weight (wet weight) of each brain slice (presented in table 3.3) was used to correct the 
final value of neurotransmitters levels in relation to slice size. The same flow rate (aCSF 
microperfusion flow) was used independently of the size of slices.  
Slice vitality was confirmed by electrophysiological population recordings test (Appendix VII), 
meaning that all the potential sources of errors during each step, were minimized. No information 
is available to make an estimation of the number of alive cells present in the slice.  
 
4.5 Release of neurotransmitters during  hypoxia 
The role of excitatory and inhibitory neurotransmitter in the brain in relation to anoxic/ischemic 
damage has been investigated already in some other different species (Nilsson, 1990, Nilsson et 
al., 1990, Lo et al., 1998, Lutz et al., 2003, Kirschner et al., 2009, Drew et al., 2013). Results from 
such studies are discussed below, under the relevant subheadings for the different compounds. 
But this is the first report of neurotransmitter efflux from the cerebellum in birds during modeled 
hypoxia. Temporal response during hypoxia exposure was investigated for the efflux of two 
neurotransmitters known to have an excitatory function in other species (Glu and Ser) (Lutz et al., 
2003, Kirschner et al., 2009, Drew et al., 2013) and one with known primarily inhibitory function 
(Gly) (Foster and Kemp, 1989, Nilsson, 1990, Nilsson et al., 1990). Results for the Thr are also given 
even if the role of this amino acid related with hypoxia in the brain is still not well known. 
Kirschner et al. (2009) showed a significant increase of Thr levels in response to ischemia in 
Sprague Dawley rats (Kirschner et al., 2009). 
Results for chicken show a generally significantly higher level of neurotransmitter efflux, both for 
control and treatment, compared with eider duck (p < 0,05) (tab. 3.4.5). As already previously 
explained, a measurement of the oxygen tension in the aCSF was not possible with the current 
instrumentation. One explanation could be given by the assumption of incomplete O2 saturation in 
the normoxic aCSF, meaning that the normoxia status could already have been a weak hypoxia. 
Since the chicken brain tissue is not adapted to hypoxia in the same way as in the eider duck 
(Ludvigsen and Folkow, 2009), a possibly slightly hypoxic condition under “normoxic” perfusion 
could possibly be manifested with high levels of neurotransmitter, but as explained before, oxygen 
tension measurements that could support this hypothesis could not be made.  
Besides, chicken slices were already proved by Ludvigsen & Folkow to be more hypoxia tolerant 




Temporal variation was not a significant factor, beside for the efflux of Glu in the eider ducks 
group, (F: 3,3005,41 p = 0,014) and for the efflux of Ser in the chickens group (F: 2,6995,41 p = 0,034), 
which showed a significant temporal fluctuation. However, only 6 pairwise comparisons between 
chicken and eider ducks have been considered, due to capacity limitations in the neurotransmitter 
analyses. More samples would need to be analysed to confirm/improve statistical analysis on 
potential temporal variations.   
Neurotransmitter levels in some of the control groups decreased significantly over time compared 
with the treatment. This is probably a proof of tissue "ageing" inside the microperfusion chamber.  
A strong individual variation, given by large standard deviation (fig. 3.4.1 –  3.4.8), was present in 
both the species and for both treatment and control.  
 
Glutamate  
The level of Glu release from eider duck slices increased significantly in response to hypoxia, while 
during reoxygenation, Glu level fell below the baseline values (fig. 3.4.1 – 3.4.2). The latter may be 
a similar phenomenon as the observed slow decrease in Glu release from the control group over 
time (fig. 3.4.1 – 3.4.2), which could be related to the ageing of the preparation and drainage of 
the supply of Glu in the slice. Glu temporal efflux variation was significant only for the eider ducks 
(p = 0,014), with a significant increase of extracellular Glu level at minute 27, confirmed by 
pairwise comparison (tab. 3.4.2). Moreover, the chickens showed higher levels of Glu for both 
control and treatment when compared with the levels released from the eider ducks. 
These results suggest that also in birds, enhanced Glu release under hypoxic conditions plays an 
important role and may contribute to excitotoxicity (Kirschner et al., 2009). Eider ducks, which are 
adapted to repeated shorts hypoxic conditions as a consequence of breath-hold diving, have 
probably delayed or attenuated release of this excitatory neurotransmitter, although this could 
not be conclusively demonstrated in the present study.  
Knowledge on temporal response of Glu to model ischemia or hypoxia are available for small 
mammals (Lo et al., 1998, Kirschner et al., 2009, Drew et al., 2013), turtle (Nilsson et al., 1990) and 
fresh water fish (Nilsson, 1990).   
In the fresh water turtle (Pseudemys scripta elegans), a species well-known to have a high 
tolerance to hypoxia (Lutz et al., 2003), Nilsson showed that the Glu level first increased, but then 




showed similar tendency in the crucian carp with a decrease by 49% after 18 days of hypoxia 
exposure (Nilsson, 1990).  
Eider duck, in comparison, showed a slight increase in Glu release after the first minutes in 
hypoxia. These seabirds, even if very good divers (diving to less than 60 m) (Hawkins et al., 2000), 
are usually used to stay under the water for less than a minute (Guillemette et al., 2004). 
Therefore, they do not need to handle long-term hypoxic condition as crucian carps and fresh 
water turtles have to, but nevertheless may be challenged with hypoxemia on a regular basis, as 
shown for example for penguins (Ponganis et al 2007). Nevertheless, comparisons of temporal 
aspects of the Glu release between  turtles/crucian carps and eider ducks are therefore difficult to 
make.   
Comparison with small mammals that were subjected to acute hypoxia is probably more relevant. 
In Sprague Dawley rats (Rattus norvegicus) and the New Zealand white rabbit (Oryctolagus 
cuniculus), Kirschner and Lo showed that there was a large elevations in the Glu concentration 
during the first 10 minutes of ischemia (Lo et al., 1998, Kirschner et al., 2009). On the contrary, 
hippocampus slice of  arctic ground squirrels showed delayed efflux of Glu during acute hypoxia 
(Drew et al., 2013). Such species was proved to be more resistant to hypoxia and ischemic-like 
condition, than hypoxia-vulnerable species such as rat.  
 
Serine 
Results for the eider ducks showed a significant increase in the level of Ser in response to hypoxia 
that persisted during the reoxygenation, as confirmed by pairwise statistical comparisons (fig. 
3.4.5).  
The chickens displayed higher levels of Ser for both control and treatment, compared to the eider 
ducks. Pairwise significant differences, between hypoxia and control, were only observed for 
chicken during reoxygenation, with a slight decrease in the Ser levels for the control group (fig. 
3.4.6).   
These results therefore suggest that also in birds Ser could act as a coagonist, at the "glycine site" 
(Shleper et al., 2005), available to activate the NMDA receptor and thereby contribute to 
excitotoxicity (Kirschner et al., 2009).  
Ser efflux was found significantly elevated throughout the ischemic period in the rabbit cortex (Lo 
et al., 1998) and in rat hippocampus slices (Kirschner et al., 2009). In hypoxia tolerant species Ser 




levels during hypoxia (Nilsson et al., 1990). In crucian carp, instead, Ser efflux remained unaltered 




Thr increases in response to hypoxia in a manner similar to that of Ser in both eider duck and 
chicken (fig. 3.4.3 – 3.4.4). According to Kirschner et al. (2009), the chemical similarity between 
Thr and Ser suggests that these two amino acids use similar transport mechanisms. Kirschner et al. 
(2009) showed an increase of Thr levels in rat hippocampus slice during OD (Kirschner et al., 2009). 
The role of this compound as a neurotransmitter is still not clear. Further investigations are 
needed to clarify its role during OD.  
 
Glycine 
Gly increases significantly in response to OD in a manner similar to that of Ser and Thr in the eider 
ducks, confirmed also by pairwise comparison. In the chickens, Gly levels remained stable and 
decreased slightly under control conditions (fig. 3.4.7 – 3.4.8). 
In mammals the role of this neurotransmitter during anoxia is ambiguous, having both inhibitory 
and excitatory proprieties (Foster and Kemp, 1989). Even though in the mammalian neocortex Gly 
is considered an allosteric activator of the glutamate receptors (NMDA), it is well established as an 
inhibitory neurotransmitter in lower brain areas (Lutz et al., 2003). Gly is an antagonists of the D-
ser (‘‘Gly’’) binding site and is neuroprotective in animal models of stroke (Wasterlain et al., 1996, 
Ohtani et al., 2000, Ohtani et al., 2003). In hypoxia tolerant species, as turtles and crucian carps, 
inhibitory neurotransmitters are released in large amounts during hypoxia exposure. They act by 
depressing neural activity and hence ATP use and thereby protect (Nilsson, 1990, Nilsson et al., 
1990). Nilsson showed that anoxia produces increased intracellular Gly concentrations in both the 
fresh water turtle (Nilsson et al., 1990) and the crucian carp (Nilsson, 1990) brain. In the rat, by 
contrast, no increase of Gly was seen during ischemia (Erecinska et al., 1984) which perhaps 
indicates an important difference in the inhibitory role of Gly between the anoxia-tolerant brain 
and the mammalian brain. The fact that the release of Gly levels increased significantly in eider 
duck slices but not in chicken slices may indicate that Gly release is enhanced in the divers, 




GABA is also a well-established inhibitory neurotransmitter, probably involved in the depression of 
the brain metabolism (Lutz et al., 2003). Surprisingly, it cannot be seen in any of the samples 
analysed by UPLC, probably because of its too low concentration.  
 
4.6 Ethics 
Eider ducks were kept in the research animal facilities at the ABB of UiT The Arctic University of 
Norway. A suitable in and outdoor facility with a small pool, during the summer and the winter 
season, ensured the well-being of these animals. Chickens were hatched and reared in similar 
conditions by a private owner, from whom they were purchased. Altogether 10 birds (6 eider 
ducks and 4 chickens) were euthanized to investigate the role of neurotrasmitter efflux from 
cerebellum slice during hypoxia. This is a minimum number to obtain scientifically and statistically 
valid information and if available, it would have been desirable to increase the number of 
chickens. An appropriate anesthetic (intramuscular injection of Ketalar (ketamine hydrochloride 
50 mg/ml, Pfizer Inc., New York, USA) and Xylazin (Rompun vet. xylazin chloride 20 mg/ml, Bayer 
AG, Leverkusen, Germany) (Green et al., 1981)) was used to avoid potential distress and pain 
during the handling procedures and before euthanasia.  
Live brain tissue was required to measure the release of neurotransmitters during simulated 
hypoxia. 
Nowadays, there are a number of alternative methods that can be used to replace the use of living 
animals. Recently, studies of the brain have improved enormously through the use of in vivo and 
in vitro models. Some future prospects could possibly be addressed in brain cell cultures, or even 
dissociated cultures of microglia, astrocytes, oligodendrocytes and neurons (Gibbons and 
Dragunow, 2010), while others require intact tissue in order to allow the interplay between 
different cells to be studied.  
 
4.7 Conclusion  
The developed method was validated with respect to specificity, linearity, quantification and 
precision. The Waters MassTrak™AAA kit proved to be a robust, reliable, and reproducible 
method. Results demonstrate that the modifications of the method (e.g. run time) made it more 




Ultra-Performance Liquid Chromatographic (UPLC) analysis of amino acids in aCSF from 
cerebellum slices of eider ducks and chickens showed results that can be compared with similar 
studies done on other species (Nilsson, 1990, Nilsson et al., 1990, Lo et al., 1998, Lutz et al., 2003, 
Kirschner et al., 2009, Drew et al., 2013).  
In agreement with previous studies (Ludvigsen and Folkow, 2009), results for eider duck and 
chicken implied a higher hypoxia tolerance since it was observed a significantly blunted release of 
excitatory transmitters (Glu and Ser). However, is not confirmed that the brain neurons of the 
eider duck display a higher hypoxia tolerance than those of chicken, since no visible significantly 
blunted release of excitatory transmitters (Glu and Ser), and/or a significantly enhanced release of 
Gly in ducks compared to chicken could be conclusively confirmed. Besides, a generally higher 
level of neurotrasmitter efflux, both for control and treatment, was observed in chicken compared 
with the eider duck.   
There was a high variation between individuals of the same species and this is possibly due to 
differences in the vitality and anatomy of the single brain slices. 
 
Future prospective 
Stroke is one of the most leading causes of death in humans. The resulting brain damage by stroke 
is a consequence of an insufficient blood supply to the brain, followed by a cascade of excitotoxic 
events as a result of insufficient oxygen supply (Ramirez et al., 2007). The hippocampus is 
considered as highly susceptible to global cerebral ischemia experienced during cardiac arrest 
(Kirino, 2000). 
Recently, brain neurons of the hooded seal (Cystophora cristata) have been shown to be more 
hypoxia tolerant than those of small mammals as the mice (Folkow et al., 2008). Microperfusion 
tests on visual cortex and hippocampus slice of hooded seals have also been performed in parallel 
with the presently described study in eider ducks and chickens. However, time and costs have 
delayed the analysis with the Ultra-Performance Liquid Chromatography and suitable control 
experiments with representative non-diving mammalian species have not yet been conducted. 
Efflux of neurotransmitter patterns, under hypoxia conditions, deserve to be investigated 
especially in a large diving mammal as the hooded seal, already tested for its extraordinary ability 
to tolerate hypoxia (Czech-Damal et al., 2014). 
In addition, more investigations should be conducted on others neurotrasmitter that have a 
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Appendix I :  
 
        





         
Flow rate syringe pump II A = 0,025 ml/min                        Flow rate syringe pump II B = 0,022 ml/min 
 
 
y = 0,0223x - 0,002 


























Syringe pump I A 
Vel 10 55% 
y = 0,0247x + 0,0003 


























Syringe pump II A 
Vel 9 
y = 0,0226x - 0,0023 


























Syringe pump I B 
Vel 10 55% 
y = 0,0239x - 0,0014 




































Appendix II :   
Waters Acquity SDS Method 
 
Solvent C Name: Water 
Solvent D Name: Acetonitrile 
Low Pressure Limit: 0 psi 
High Pressure Limit: 15000 psi 
Seal Wash Period: 5.00 min 
[Gradient Table] 
Time(min) Flow Rate(mL/min) %A %B %C %D Curve 
1. Initial 0.400 0.0 0.0 99.9 0.1 Initial 
2. 1.14 0.400 0.0 0.0 99.9 0.1 6 
3. 5.00 0.400 0.0 0.0 98.5 1.5 6 
4. 10.00 0.400 0.0 0.0 95.0 5.0 6 
5. 20.00 0.400 0.0 0.0 80.0 20.0 6 
6. 25.00 0.400 0.0 0.0 2.0 98.0 6 
7. 28.00 0.400 0.0 0.0 2.0 98.0 6 
8. 28.10 0.400 0.0 0.0 99.9 0.1 6 
9. 32.00 0.400 0.0 0.0 99.9 0.1 6 
 
Flow Ramp Rate: 0.45 min 
 
Run Time: 32.00 min 
Load Ahead: Disabled 
Loop Offline: Automatic min 
Wash Solvent Name: Water 
Pre-Inject Wash Time: 6.0 sec 
Post-Inject Wash Time: 6.0 sec 
Purge Solvent Name: Water 
Dilution: Disabled 
Dilution Volume: 0 uL 
Delay Time: 0 min 
Dilution Needle Placement: 4 mm 
Target Column Temperature: Off C 
Target Sample Temperature: Off C 
Sample Temperature Alarm Band: 25.0 C 
Syringe Draw Rate: 30 uL/min 
Needle Placement: Automatic 
y = 0,0222x + 0,0002 





























Pre-Aspirate Air Gap: Automatic 
Post-Aspirate Air Gap: Automatic 
 
 
Waters Acquity PDA Method 
 
Run Time: 32.00 min 
PDA Detector Type: UPLC LG 500 nm 
Lamp: On 
Sampling Rate: 20 points/sec 
Filter Time Constant: 0.1000 sec 
Exposure Time: Auto msec 
Negative Absorbance Margin: -0.07 AU 
Interpolate 2nd order filter (340nm) Region: No 
Use UV Blocking Filter: No 
Range: 210 - 500 
Resolution: 1.2 nm 
Initial Switch 1: No Change 
Pulse Width: 1.0 sec 
Rect Wave Period: 0.2 sec 
 
 
Waters Acquity CM Method 
 
Target Column Temperature: 43.0 C 
Column Temperature Alarm Band: 2.0 C 
Column Valve Position: Column 1 
 
 
Appendix III:  
List of Chemicals  
D-Norvaline, Synonym: (R)-(−)-2-Aminopentanoic acid, 99% code 851620, Sigma-Aldrich Co. LLC  
St. Louis, Missouri 
Ketalar, ketamine hydrochloride 50 mg/ml, Pfizer Inc., New York, USA 
Xylazin, Rompun vet. xylazin chloride 20 mg/ml, Bayer AG, Leverkusen, Germany 
AccQ•Tag Ultra Derivatization Kit, 250 analyses [186003836]  Instruction manual: 
http://www.waters.com/webassets/cms/support/docs/715001331.pdf 
AccQ-Tag Eluent A [WAT052890] 
AccQ-Tag Ultra Eluent B [186003839] 









Appendix IV:  
Cleaning protocol: One-time cleaning (enough to be performed only once) 
Cleaning solvents: 
A) 50:50 (v/v) methanol : water  
B) 30:70 (v/v) phosphoric acid : water 
C) 100% water 
D) 100% isopropanol  
 
To clean the system: 
1) Place all lines A1, A2, B1, B2 seal wash, and strong needle wash into A) 50:50 methanol : 
water. 
2) Prime the solvent lines for 5 minutes each.   
3) Prime the seal wash. 
4) Prime the wash syringes and sample syringe for 4 cycles. 
5) Connect a pressure restrictor in the fluid path after the injector to create 2000 psi 
backpressure in the system.  
6) Transfer 1 mL of mobile phase to an auto sampler vial and place it in position 1:A, 1. 
7) Create an instrument method with the following parameters:                                                   
•Flow rate = 0.5 mL/min                                                                                                                       
•Gradient composition 50% A1:50% B1                                                                                             
•Full loop injection (2X overfill) 
8) Make 30 full loop injections from the vial containing the mobile phase. Set the run time to 
0.5 minutes. 
9) Repeat steps 1 through 8 using 100% isopropanol as the solvent.                                         
Restriction: Do not pass effluent through the optical detector for this wash step. Route the 
restrictor to waste 
10)  Repeat steps 1 through 8 using 100% water as the solvent. 
11) Repeat steps 1 through 8 using 30:70 (v/v) phosphoric acid : water as the solvent. 
12) Repeat steps 1 through 8 using 100% water as the solvent. 
13) Repeat steps 1 through 8 using 50:50 (v/v) methanol : water as the solvent. 





Cleaning protocol: Each time cleaning  (to be performed before start to run a new set of samples) 
1) Install Eluent A on line A1 and Eluent B on lines B1 and B2. 
2) Install the Seal Wash line into a 80:20 (v/v) water/acetonitrile solution. 
3) Install the Strong Needle Wash line into a 95:5 (v/v) acetonitrile/water solution. 
4) Prime all solvent lines for 5 minutes. 
5) Prime wash/sample syringes for 4 cycles. 
6) Run the method for at least 30 minutes.  
Tip: This test takes approximately one hours. 
 
 






y = 0,1868x - 0,0059 
R² = 1 
y = 0,1976x - 0,0098 
R² = 0,9999 
y = 0,1983x - 0,0105 































y = 0,2049x - 0,0076 
R² = 0,9998 
y = 0,1953x - 0,0046 
R² = 0,9998 
y = 0,2028x - 0,0035 























y = 0,2042x - 0,0086 
R² = 0,9998 
y = 0,1918x - 0,0049 
R² = 0,9998 
y = 0,1993x - 0,0042 























y = 0,2062x - 0,0082 
R² = 0,9999 
y = 0,1973x - 0,0055 
R² = 0,9999 
y = 0,2001x - 0,0051 


























Appendix VI :  
Statistical analysis  
Linear Mixed Model based on the Bonferroni correction used to determine significant differences 
between treatment and control (Exp). 
 
 
Tests of Fixed Effects
a
 
Source Numerator df Denominator df F Sig. 
Intercept 1 41 384.648 .000 
Exp 1 41 25.735 .000 
Time 5 41 3.300 .014 
a. Chemical = glutamate, Species = Eider  
The F tests the effect of Exp. This test is based on the linearly independent pairwise 




Tests of Fixed Effects
a
 
Source Numerator df Denominator df F Sig. 
Intercept 1 46 555.228 .000 
Exp 1 46 4.862 .032 
  a. Chemical = glutamate, Species = Chicken 
 The F tests the effect of Exp. This test is based on the linearly independent                          





Tests of Fixed Effects
a
 
Source Numerator df Denominator df F Sig. 
Intercept 1 46 2566.966 .000 
Exp 1 46 55.678 .000 
a. Chemical = threonine, Species = Eider 
The F tests the effect of Exp. This test is based on the linearly independent pairwise 




Tests of Fixed Effects
a
 
Source Numerator df Denominator df F Sig. 
Intercept 1 46 1427.406 .000 
Exp 1 46 25.480 .000 
a. Chemical = threonine, Species = Chicken 
The F tests the effect of Exp. This test is based on the linearly independent pairwise 






Tests of Fixed Effects
a
 
Source Numerator df Denominator df F Sig. 
Intercept 1 46 1915.563 .000 
Exp 1 46 66.995 .000 
a. Chemical = serine, Species = Eider 
The F tests the effect of Exp. This test is based on the linearly independent pairwise 




Tests of Fixed Effects
a
 
Source Numerator df Denominator df F Sig. 
Intercept 1 41 849.116 .000 
Exp 1 41 40.898 .000 
Time 5 41 2.699 .034 
a. Chemical = serine, Species = Chicken 
The F tests the effect of Exp. This test is based on the linearly independent pairwise 








Tests of Fixed Effects
a
 
Source Numerator df Denominator df F Sig. 
Intercept 1 46 2140.438 .000 
Exp 1 46 109.735 .000 
 a. Chemical = glycine, Species = Eider 
The F tests the effect of Exp. This test is based on the linearly independent pairwise 





Tests of Fixed Effects
a
 
Source Numerator df Denominator df F Sig. 
Intercept 1 46 1415.531 .000 
Exp 1 46 24.039 .000 
 a. Chemical = glycine, Species = Chicken  
The F tests the effect of Exp. This test is based on the linearly independent pairwise 







Linear Mixed Model based on the Bonferroni correction used to determine significant differences 
in the effect of treatment, between the eider duck and chicken group. 
 
 
Tests of Fixed Effects
a
 
Source Numerator df Denominator df F Sig. 
Intercept 1 86 540.747 .000 
Species 1 86 18.966 .000 
a. Chemical = glutamate, Exp = control  
The F tests the effect of Species. This test is based on the linearly independent pairwise 
comparisons among the estimated marginal means. 
 
 
Tests of Fixed Effects
a
 
Source Numerator df Denominator df F Sig. 
Intercept 1 41 559.197 .000 
Time 5 41 3.230 .015 
Species 1 41 5.439 .025 
a. Chemical = glutamate, Exp = hypoxia  
The F tests the effect of Species. This test is based on the linearly independent pairwise 
comparisons among the estimated marginal means. 
 
 
Tests of Fixed Effects
a
 
Source Numerator df Denominator df F Sig. 
Intercept 1 86 4065.045 .000 
Species 1 86 39.572 .000 
a. Chemical = threonine, Exp = control  
The F tests the effect of Species. This test is based on the linearly independent pairwise 
comparisons among the estimated marginal means. 
.  
 
Tests of Fixed Effects
a
 
Source Numerator df Denominator df F Sig. 
Intercept 1 86 2894.236 .000 
Species 1 86 24.107 .000 
 a. Chemical = threonine, Exp = hypoxia  
The F tests the effect of Species. This test is based on the linearly independent pairwise 














Tests of Fixed Effects
a
 
Source Numerator df Denominator df F Sig. 
Intercept 1 86 1697.683 .000 
Species 1 86 5.513 .021 
a. Chemical = serine, Exp = control 
The F tests the effect of Species. This test is based on the linearly independent pairwise 





Tests of Fixed Effects
a
 
Source Numerator df Denominator df F Sig. 
Intercept 1 86 2115.913 .000 
Species 1 86 14.246 .000 
a. Chemical = serine, Exp = hypoxia 
The F tests the effect of Species. This test is based on the linearly independent pairwise 






Tests of Fixed Effects
a
 
Source Numerator df Denominator df F Sig. 
Intercept 1 86 3091.495 .000 
Species 1 86 59.115 .000 
a. Chemical = glycine, Exp = control  
The F tests the effect of Species. This test is based on the linearly independent pairwise 






Tests of Fixed Effects
a
 
Source Numerator df Denominator df F Sig. 
Intercept 1 85 2277.422 .000 
Species 1 85 4.770 .032 
a. Chemical = glycine, Exp = hypoxia The F tests the effect of Species.  









Statistics for pairwise comparison 
Only one example is here attached: Chemical = glutamate, minute = 27,  Species = Eider 
 
Tests of Fixed Effects
a
 
Source Numerator df Denominator df F Sig. 
Intercept 1 6 62.399 .000 
Exp 1 6 6.213 .047 

















































Fixed Effects Intercept 1 1 
Exp 2 1 
Residual  1 
Total 3 3 














(I) Exp (J) Exp 
Mean Difference 
(I-J) Std. Error df Sig.
d
 




Lower Bound Upper Bound 
control hypoxia -326.141
*
 130.846 6 .047 -646.310 -5.973 
hypoxia control 326.141
*
 130.846 6 .047 5.973 646.310 
Based on estimated marginal means 
*. The mean difference is significant at the ,05 level. 
a. Chemical = glutamate, Time = 27:00, Species = Eider 









Figure A: A typical recording cerebellum slice of a chicken, after 20 minutes hypoxia treatment. In: Stimulator in 
contact with the cerebellum slice. Out: The stimulator is not touching the cerebellum slice. X-axis: Time recording. Y-






Figure B: A typical recording cerebellum slice of an eider duck, after 20 minutes hypoxia treatment. In: Stimulator in 
contact with the cerebellum slice. Out: The stimulator is not touching the cerebellum slice. X-axis: Time recording. Y-
axis: Membrane potential (µV). 
 
